protein

Recombinant Human LR3 IGF-I/IGF-1 GMP Protein, CF

8335D-GMP-200

200 ug

121 USD

8335D-GMP

8335D-GMP-200

Recombinant Human LR3 IGF-I/IGF-1 GMP Protein, CF

200 ug

The Recombinant Human Serpin A12 Protein, CF from R&D Systems is derived from NS0. The Recombinant Human Serpin A12 Protein, CF has been validated for the following applications: Enzyme Activity.

IGF-I/IGF-1

Proteins and Enzymes

IBP1, IGF1, IGF-1, IGF1A, IGFI, IGF-I, IGF-IA, IGF-IB, insulin-like growth factor 1, insulin-like growth factor 1 (somatomedin C), insulin-like growth factor I, insulin-like growth factor IA, insulin-like growth factor IB, Mechano growth factor, MGF, Somatomedin A, Somatomedin C, Somatomedin-C

Lyophilized from a 0.2 µm filtered solution in Acetic Acid.

Unconjugated

Unconjugated

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. The result of the major peak from mass spectrometry analysis is 9111 Da, which corresponds to the calculated molecular mass of 9118 Da.

Human

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. A minimum of 12 months when stored at <= -20 °C as supplied. Refer to lot specific COA for the Use by Date. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.

8 kDa, reducing conditions

9 kDa

Measured in a serum-free cell proliferation assay using MCF-7 human breast cancer cells. Karey, K.P. et al . (1988) Cancer Research 48 :4083. The ED50 for this effect is 0.3-1.5 ng/mL. IGFBP-3 does not inhibit its activity.

<0.01 EU per 1 µg of the protein by the LAL method.

P05019

Bioactivity

E. coli-derived Recombinant Human LR3 IGF-I/IGF-1 GMP Protein, CF

Animal-Free

112

121 USD

Animal-Free

200 ug (also 1 mg)